GrandOmics focuses on the application of long-read sequencing technology；we developed sequencing solutions for different biology research fields by integrating the advantages of multiple sequencing platforms, including NGS and Long-read Sequencing.
GrandOmics also actively engaged in the independent development of bioinformatics software and explore the application of long-read sequencing technology in clinical medicine. In response to the data processing problems of the long read sequencing technology in the application fields of animal and plant genome research, pathogenic microorganism detection, and clinical testing, we have developed NextDenovo, NextPolish, GrandBox, GrandPathogen and other bio-information algorithms and platforms to analysis genomic data.
Contact us now at inquiry@grandomics.com. We are so glad to assist your genomics research – we’d love to hear from you!
Company Details
- Employees
- 8
- Founded
- -
- Address
- Zhongguancun Life Science Park, Changping District,, Innovation Building D301,china
- Industry
- Biotechnology
- Website
- http://www.grandomics.com/en
- HQ
- Beijing, China
Grandomics Biosciences Questions
Grandomics Biosciences's website is http://www.grandomics.com/en
Grandomics Biosciences's LinkedIn profile is https://cn.linkedin.com/company/grandomics-bioscience
Grandomics Biosciences has
8 employees.
View email and phone details for 8
employees at Grandomics Biosciences.
Grandomics Biosciences's industry is
Biotechnology
Grandomics Biosciences's top competitors are
Novogene,
Edenroc Sciences, Llc,
Leymus Genomics,
Takara Bio Inc.,
Azenta Life Sciences,
Revolugen Ltd,
Bgi Group,
Takara Bio Usa, Inc.,
Baseclear,
Cd Genomics.
Grandomics Biosciences's categories are Biotechnology
Grandomics Biosciences's founding year is 2011
